Discovery and preclinical pharmacology of EC330: A first-in-class leukemia inhibitory factor (LIF) inhibitor
Nair, H.B, Santhamma, B, Viswanadhapalli, S, Sareddy, G.R, Manthati, V, Vadlamudi, R.K, Nickisch, K.J
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
63 - Discovery and preclinical pharmacology of EC330: A first-in-class leukemia inhibitory factor (LIF) inhibitor
Nair, H.B., Santhamma, B., Viswanadhapalli, S., Sareddy, G.R., Manthati, V., Vadlamudi, R.K., Nickisch, K.J.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Abstract P2-06-02: Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer
Viswanadhapalli, S, Luo, Y, Sareddy, GR, Santhamma, B, Zhou, M, Li, M, Pratap, UP, Altwegg, KA, Li, X, Srinivasan, U, Ma, S, Chang, A, Riveros, AC, Zhang, KY, Dileep, KV, Pan, X, Murali, R, Bajda, M, Raj, G, Brenner, A, Manthati, V, Rao, M, Tekmal, RR, Nair, HB, Nickisch, KJ, Vadlamudi, RK
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article